ArticleCancer gene therapy2011
An oncolytic adenovirus defective in pRb-binding (dl922-947) can efficiently eliminate pancreatic cancer cells and tumors in vivo in combination with 5-FU or gemcitabine.
M Bhattacharyya et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papertrialcites it